Objectives Beta-blockers have long been successfully used for the treatment of both supraventricular and ventricular arrhythmias. However, differences exist between their …
S Ray, T Nair, J Sawhney, Erwinanto… - Current Medical …, 2023 - Taylor & Francis
Abstract Objective This Delphi method of consensus was designed to develop scientific statements for β-blockers in the continuum of cardiovascular diseases with a special focus …
Sudden cardiac death (SCD) is one of the most common causes of death in the world. Coronary heart disease (CHD) is the root cause of most patients with SCD, and myocardial …
Y Wang - Computational and Mathematical Methods in …, 2022 - Wiley Online Library
Background. Bisoprolol is commonly used to treat moderate or severe chronic stable heart failure, coronary heart disease, and hypertension. This study is aimed at analyzing the …
S Momčilović, JR Milovanović… - Journal of …, 2019 - journals.lww.com
To date, many questions about the extent and cause of pharmacokinetic (PK) variability of even the most widely studied and prescribed β1-adrenergic receptor blockers, such as …
N Dagres, G Hindricks - Cardiac Electrophysiology Clinics, 2017 - cardiacep.theclinics.com
Sudden cardiac death is a major cause of mortality in acute coronary syndromes, mostly caused by complex ventricular arrhythmias, in particular, ventricular fibrillation (VF). This …